Analysis of the direct cost of medical and surgical care for breast cancer. Comparative study between early and advanced stages in the third level medical facility

被引:0
|
作者
Montiel-Jarquin, Alvaro J. [1 ]
Santiago-Carrillo, Marco A. [1 ,2 ]
Garcia-Galicia, Arturo [1 ]
Lopez-Bernal, Carlos A. [1 ]
Miranda-Martinez, Miriam A. [1 ]
Loria-Castellanos, Jorge [3 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Med Alta Especialidad Hosp Especialidades, Ctr Med Nacl Gen Div Manuel Avila Camacho, Puebla, Pue, Mexico
[2] Benemerita Univ Autonoma Puebla, Fac Med, Puebla, Pue, Mexico
[3] Inst Mexicano Seguro Social, Coordinac Proyectos Especiales Salud, Puebla, Pue, Mexico
来源
CIRUGIA Y CIRUJANOS | 2023年 / 91卷 / 01期
关键词
Breast cancer; Direct cost; Medical attention; Late diagnosis;
D O I
10.24875/CIRU.21000624
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Management of breast cancer is increased by late diagnoses. Objective: To analyse direct costs of breast cancer in early and advanced stage in a third level medical facility at Mexican Social Security Institute. Method: Observational study, direct costs of care in breast cancer in initial and advanced clinical stages are compared. Variables analysed were laboratory and diagnostic imaging studies, drugs, as well as hospitalization costs. The evaluated period included from the first care to the completion of the treatment. Costs were determined according to the table of Unit Costs by Level of Medical Care for the year 2019 of the Mexican Social Security Institute. Student's t test was used to determinate differences between groups, as well as descriptive statistics. Results: The advanced stage compared to the initial stage, causes a greater num-ber of laboratory-cabinet studies, surgeries, day/bed and interconsultations. The average cost of breast cancer care per patient is $99,280.36 (US$5,230.78) and $148,023.60 (US$7,789.92) for the initial and advanced stages, respectively (p = 0.024). Conclusions: Cost of medical attention in the initial stage is lower than that of the advanced stage.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 36 条
  • [1] Analysis of the Direct Cost of Medical and Surgical Care for Testicular Cancer in Early and Advanced Stages in a Third Level Medical Facility of the Mexican Social Security Institute
    Montiel-Jarquin, Alvaro Jose
    Vargas-Huerta, Margarita L.
    Maldonado-Castafieda, Sandra
    Garcia-Galicia, Arturo
    Ibarra-Zamarron, Sebastian L.
    Loria-Castellanos, Jorge
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (06): : 489 - 493
  • [2] The cost of cancer - A comparative analysis of the direct medical costs of cancer and other major chronic diseases in Europe
    Schlueter, Max
    Chan, Katie
    Lasry, Romain
    Price, Martin
    [J]. PLOS ONE, 2020, 15 (11):
  • [3] A comparative study on the effect of palliative care between palliative care team and medical oncologists in patients with advanced cancer at Phramongkutklao Hospital
    Pornrattanakavee, P.
    Prasongsook, N.
    Saichaemchan, S.
    Seetalarom, K.
    Oer-Areemitr, N.
    Srichan, T.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1081 - S1082
  • [4] COMPARATIVE ANALYSIS OF NATURAL KILLER CELL ACTIVITY BETWEEN ADVANCED BREAST CANCER AND EARLY BREAST CANCER
    Kim, Jae Il
    Kwak, Beom Seok
    [J]. BREAST, 2019, 48 : S41 - S42
  • [5] The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective Study
    Yoon, Seok-Jun
    Kim, Eun-Jung
    Seo, Hyun-Ju
    Oh, In-Hwan
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [6] Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study
    Hequet, Delphine
    Huchon, Cyrille
    Soilly, Anne-Laure
    Asselain, Bernard
    Berseneff, Helene
    Trichot, Caroline
    Combes, Aline
    Alves, Karine
    Thuy Nguyen
    Rouzier, Roman
    Baffert, Sandrine
    [J]. PLOS ONE, 2019, 14 (07):
  • [7] Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
    Schneider, Paul Peter
    Ramaekers, Bram L.
    Pouwels, Xavier
    Geurts, Sandra
    Ibragimova, Khava
    de Boer, Maaike
    Vriens, Birgit
    van de Wouw, Yes
    den Boer, Marien
    Pepels, Manon
    Tjan-Heijnen, Vivianne
    Joore, Manuela
    [J]. VALUE IN HEALTH, 2021, 24 (05) : 668 - 675
  • [8] Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
    Force, Rex W.
    Pugmire, Brooke A.
    Culbertson, Vaughn L.
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2010, 3 (04): : 276 - 284
  • [9] COMPARATIVE COST-EFFECTIVENESS OF DRUGS IN EARLY VERSUS LATE STAGES OF CANCER; REVIEW OF THE LITERATURE AND A CASE STUDY IN BREAST CANCER
    Dvortsin, E.
    Eijssen, E. M.
    van Brussel, J.
    Gout-Zwart, J.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A487 - A487
  • [10] Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer
    Dvortsin, Evgeni
    Gout-Zwart, Judith
    Eijssen, Ernst-Lodewijk Marie
    van Brussel, Jan
    Postma, Maarten J.
    [J]. PLOS ONE, 2016, 11 (01):